Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| 1 |
NVIDIA
NVDA
|
$1.79B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$448M |
| 3 |
AbbVie
ABBV
|
$307M |
| 4 |
Capital One
COF
|
$269M |
| 5 |
Southwest Airlines
LUV
|
$264M |
Top Sells
| 1 |
Microsoft
MSFT
|
$1.26B |
| 2 |
GE Aerospace
GE
|
$1.06B |
| 3 |
Lowe's Companies
LOW
|
$537M |
| 4 |
Meta Platforms (Facebook)
META
|
$352M |
| 5 |
Apple
AAPL
|
$350M |
Sector Composition
| 1 | Technology | 23.5% |
| 2 | Financials | 11.92% |
| 3 | Healthcare | 10.85% |
| 4 | Consumer Discretionary | 8.64% |
| 5 | Industrials | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBAY
3701
DELISTED
Cymabay Therapeutics
CBAY
| $120K | ﹤0.01% |
32,645
-1,705
| -5% | -$6.27K |
|
|
PMBC
3702
DELISTED
Pacific Mercantile Bancorp
PMBC
| $119K | ﹤0.01% |
12,907
-93
| -0.7% | -$857 |
|
3703
Xeris Biopharma Holdings
XERS
$1.26B
| $118K | ﹤0.01% |
48,200
-400
| -0.8% | -$979 |
|
|
HIX
3704
Western Asset High Income Fund II
HIX
$388M
| $117K | ﹤0.01% |
16,285
-11,539
| -41% | -$82.9K |
|
3705
Verastem
VSTM
$572M
| $116K | ﹤0.01% |
37,500
+3,900
| +12% | +$12.1K |
|
3706
inTEST
INTT
$88.6M
| $116K | ﹤0.01% |
+10,100
| New | +$116K |
|
3707
Amplify Energy
AMPY
$165M
| $115K | ﹤0.01% |
+21,642
| New | +$115K |
|
3708
Workhorse Group
WKHS
$20M
| $115K | ﹤0.01% |
15,065
+3,134
| +26% | +$23.9K |
|
3709
Eterna Therapeutics
ERNA
$10.2M
| $110K | ﹤0.01% |
+11,855
| New | +$110K |
|
|
BKCC
3710
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $107K | ﹤0.01% |
27,586
+2,715
| +11% | +$10.5K |
|
|
JHAA
3711
DELISTED
Nuveen Corporate Income 2023 Target Term Fund
JHAA
| $107K | ﹤0.01% |
10,833
-2,162
| -17% | -$21.4K |
|
|
CHMI
3712
Cherry Hill Mortgage Investment Corp
CHMI
$103M
| $106K | ﹤0.01% |
11,934
+167
| +1% | +$1.48K |
|
3713
Neurogene
NGNE
$276M
| $104K | ﹤0.01% |
14,340
+150
| +1% | +$1.09K |
|
|
MCBC
3714
DELISTED
Macatawa Bank Corp
MCBC
| $103K | ﹤0.01% |
12,748
-960
| -7% | -$7.76K |
|
3715
Atossa Therapeutics
ATOS
$99M
| $97K | ﹤0.01% |
29,847
+16,470
| +123% | +$53.5K |
|
|
BMTX
3716
DELISTED
BM Technologies, Inc.
BMTX
| $97K | ﹤0.01% |
10,878
-19,991
| -65% | -$178K |
|
3717
Amneal Pharmaceuticals
AMRX
$3B
| $96K | ﹤0.01% |
17,950
+100
| +0.6% | +$535 |
|
|
AUTL
3718
Autolus Therapeutics
AUTL
$391M
| $95K | ﹤0.01% |
+14,503
| New | +$95K |
|
3719
ProQR Therapeutics
PRQR
$247M
| $94K | ﹤0.01% |
11,200
-1,200
| -10% | -$10.1K |
|
3720
Gold Fields
GFI
$31.5B
| $92K | ﹤0.01% |
+11,286
| New | +$92K |
|
3721
RLX Technology
RLX
$3.16B
| $92K | ﹤0.01% |
+20,339
| New | +$92K |
|
3722
CEMIG Preferred Shares
CIG
$5.64B
| $91K | ﹤0.01% |
36,149
+932
| +3% | +$2.35K |
|
|
PGRE
3723
Paramount Group
PGRE
$1.6B
| $91K | ﹤0.01% |
10,066
-515
| -5% | -$4.66K |
|
3724
Harmony Gold Mining
HMY
$9.65B
| $88K | ﹤0.01% |
27,668
-600
| -2% | -$1.91K |
|
3725
Turkcell
TKC
$4.83B
| $85K | ﹤0.01% |
19,510
-5,630
| -22% | -$24.5K |
|